The main neurological manifestation of COVID-19 is loss of smell or taste. The high incidence
of smell loss without significant rhinorrhea or nasal congestion suggests that SARS-CoV-2 …

Obesity and metabolic dysfunction are both correlated with increased rates of cognitive decline.
However, because these two conditions often co-occur, it remains unclear whether their …

Recent anecdotal and scientific reports have provided evidence of a link between COVID-19
and chemosensory impairments, such as anosmia. However, these reports have …

In a preregistered, cross-sectional study, we investigated whether olfactory loss is a reliable
predictor of COVID-19 using a crowdsourced questionnaire in 23 languages to assess …

Background: Sudden smell loss is a specific early symptom of COVID-19, which, prior to the
emergence of Omicron, had estimated prevalence of~ 40% to 75%. Chemosensory …

Predictive models in neuroimaging are increasingly designed with the intent to improve risk
stratification and support interventional efforts in psychiatry. Many of these models have …

In response to the COVID-19 pandemic, many governments have taken drastic measures to
avoid an overflow of intensive care units. Accurate metrics of disease spread are critical for …

Chemosensory impairments have been established as a specific indicator of COVID-19.
They affect most patients and may persist long past the resolution of respiratory symptoms, …

Importance Sudden smell loss is a specific early symptom of COVID-19, with an estimated
prevalence of ∼40% to 75%. Smell impairment affects physical and mental health, and …

Peripheral sources of individual variation in taste intensity perception have been well described.
The existence of a central source has been proposed but remains unexplored. Here we …